Inspire Post Approval Study

Inspire Post Approval Study

"The purpose of this study is to obtain additional long-term safety and efficacy data on the use of Inspire therapy developed to treat moderate to severe obstructive sleep apnea."

Please use this link for further information:

Primary Investigator: Joseph Hellmann

Follow up only

Disclaimer: Patients must have an existing, documented diagnosis to be entered into some trials.
Copyright © 2024 All rights reserved.

Web Design by TBH Creative